Cardium Therapeutics, Inc.

Cardiovascular-focused company completes corporate reorganization

Published in Disease Risk Factor Week, February 19th, 2006

Cardium Therapeutics, Inc., (ARVT) announced the successful completion of its corporate reorganization, the election of its new board of directors, and the approval of a number of other proposals at an annual meeting of stockholders held January 17, 2006.

In connection with the corporate reorganization, Cardium's former parent, Aries Ventures, Inc., was merged with and into Cardium Therapeutics, Inc., a Delaware corporation. Cardium expects to provide an update shortly regarding its new trading symbol once it has been issued. Cardium also announced the filing of a resale registration statement on Form SB-2 with the U.S. Securities and Exchange Commission, which is...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Disease Risk Factor Week

Source: Disease Risk Factor Week (2006-02-19)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry